Reported sales decreased 3.7%; organic sales increased 3.5% Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidance ST. PAUL, ...
Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...
Million Acquisition of the Covelya Group Will Be Partially Financed Through a $350 Million Public Offering of Subscription ...
The S&P/ASX 200 is set to open sharply lower amid a major escalation in the Middle East. Here are today's top stories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results